Highlights and Quick Summary
- Selling, General and Administrative (SG&A) Expenses Growth for the quarter ending December 31, 2022 was 8.69% (a -245.56% decrease compared to previous quarter)
- Year-over-year quarterly Selling, General and Administrative (SG&A) Expenses Growth decreased by -70.97%
- Annual Selling, General and Administrative (SG&A) Expenses Growth for 2022 was 2.06% (a -70.4% decrease from previous year)
- Annual Selling, General and Administrative (SG&A) Expenses Growth for 2021 was 6.96% (a -25.64% decrease from previous year)
- Annual Selling, General and Administrative (SG&A) Expenses Growth for 2021 was 9.36% (a 30.0% increase from previous year)
- Twelve month Selling, General and Administrative (SG&A) Expenses Growth ending December 31, 2022 was 5.59% (a -294.77% decrease compared to previous quarter)
- Twelve month trailing Selling, General and Administrative (SG&A) Expenses Growth increased by 2229.17% year-over-year
Trailing Selling, General and Administrative (SG&A) Expenses Growth for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| 5.59% | -2.87% | 2.06% | 0.24% |
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Selling, General and Administrative (SG&A) Expenses Growth of Benitec Biopharma Limited
Most recent Selling, General and Administrative (SG&A) Expenses Growthof BNTC including historical data for past 10 years.Interactive Chart of Selling, General and Administrative (SG&A) Expenses Growth of Benitec Biopharma Limited
Benitec Biopharma Limited Selling, General and Administrative (SG&A) Expenses Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | 8.69% | -5.97% | 1.17% | 29.93% | 2.06% |
| 2021 | -18.81% | 11.16% | -6.12% | -20.05% | 6.96% |
| 2020 | 14.48% | 144.93% | 197.06% | 198.89% | 7.2% |
| 2019 | – | – | -9.78% | -59.17% | 0.0% |
| 2018 | – | – | – | – | -55.98% |
| 2017 | – | – | – | -66.34% | -28.91% |
| 2016 | – | – | – | -66.54% | -26.66% |
| 2015 | – | – | – | – | 87.57% |
| 2014 | – | – | – | – | 6.79% |
| 2013 | – | – | – | – | -6.36% |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology